Your browser doesn't support javascript.
loading
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.
Taddei, Maria Letizia; Giannoni, Elisa; Morandi, Andrea; Ippolito, Luigi; Ramazzotti, Matteo; Callari, Maurizio; Gandellini, Paolo; Chiarugi, Paola.
Afiliação
  • Chiarugi P; Department of Experimental and Clinical Biomedical Sciences, Tuscany Tumor Institute, University of Florence, viale Morgagni 50, Florence 50134, Italy. paola.chiarugi@unifi.it.
Cell Commun Signal ; 12: 24, 2014 Apr 01.
Article em En | MEDLINE | ID: mdl-24690323
ABSTRACT

BACKGROUND:

Cellular plasticity confers cancer cells the ability to adapt to microenvironmental changes, a fundamental requirement for tumour progression and metastasis. The epithelial to mesenchymal transition (EMT) is a transcriptional programme associated with increased cell motility and stemness. Besides EMT, the mesenchymal to amoeboid transition (MAT) has been described during tumour progression but to date, little is known about its transcriptional control and involvement in stemness. The aim of this manuscript is to investigate (i) the transcriptional profile associated with the MAT programme and (ii) to study whether MAT acquisition in melanoma cancer cells correlates with clonogenic potential to promote tumour growth.

RESULTS:

By using a multidisciplinary approach, we identified four different treatments able to induce MAT in melanoma cells EphA2 overexpression, Rac1 functional inhibition using its RacN17 dominant negative mutant, stimulation with Ilomastat or treatment with the RhoA activator Calpeptin. First, gene expression profiling identified the transcriptional pathways associated with MAT, independently of the stimulus that induces the MAT programme. Notably, gene sets associated with the repression of mesenchymal traits, decrease in the secretion of extracellular matrix components as well as increase of cellular stemness positively correlate with MAT. Second, the link between MAT and stemness has been investigated in vitro by analysing stemness markers and clonogenic potential of melanoma cells undergoing MAT. Finally, the link between MAT inducing treatments and tumour initiating capability has been validated in vivo.

CONCLUSION:

Taken together, our results demonstrate that MAT programme in melanoma is characterised by increased stemness and clonogenic features of cancer cells, thus sustaining tumour progression. Furthermore, these data suggest that stemness is not an exclusive feature of cells undergoing EMT, but more generally is associated with an increase in cellular plasticity of cancer cells.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Regulação Neoplásica da Expressão Gênica / Transição Epitelial-Mesenquimal / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Commun Signal Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Regulação Neoplásica da Expressão Gênica / Transição Epitelial-Mesenquimal / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Commun Signal Ano de publicação: 2014 Tipo de documento: Article